An investigation on behalf of investors in Zosano Pharma Corp (NASDAQ:ZSAN) shares over potential wrongdoing at Zosano Pharma was announced and NASDAQ:ZSAN stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 03/08/2016 --An investigation for shareholders in Zosano Pharma Corp (NASDAQ:ZSAN) was announced over potential breaches of fiduciary duties by certain Zosano Pharma directors.

Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Zosano Pharma directors breached their fiduciary duties and caused damage to the company and its shareholders.

Fremont, CA based Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Zosano Pharma Corp went public in January 2015 and shares of Zosano Pharma Corp (NASDAQ:ZSAN) grew to as high as $11.67 per share in March 2015. Since then shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined to as low as $2.00 per share on January 20, 2016.

Those who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com